FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...